PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcome
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
PubMed
31600779
DOI
10.1093/hmg/ddz237
PII: 5584440
Knihovny.cz E-zdroje
- MeSH
- adenylsukcinátlyasa nedostatek MeSH
- autistická porucha MeSH
- fatální výsledek MeSH
- fenotyp MeSH
- karboxylyasy genetika metabolismus MeSH
- lidé MeSH
- mnohočetné abnormality genetika MeSH
- mutace MeSH
- novorozenec MeSH
- peptidsynthasy genetika metabolismus MeSH
- perinatální smrt MeSH
- poruchy metabolismu purinů a pyrimidinů MeSH
- puriny biosyntéza metabolismus MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Dánsko MeSH
- Názvy látek
- adenylsukcinátlyasa MeSH
- karboxylyasy MeSH
- peptidsynthasy MeSH
- phosphoribosylaminoimidazole carboxylase MeSH Prohlížeč
- phosphoribosylaminoimidazole-succinocarboxamide synthetase MeSH Prohlížeč
- puriny MeSH
We report for the first time an autosomal recessive inborn error of de novo purine synthesis (DNPS)-PAICS deficiency. We investigated two siblings from the Faroe Islands born with multiple malformations resulting in early neonatal death. Genetic analysis of affected individuals revealed a homozygous missense mutation in PAICS (c.158A>G; p.Lys53Arg) that affects the structure of the catalytic site of the bifunctional enzyme phosphoribosylaminoimidazole carboxylase (AIRC, EC 4.1.1.21)/phosphoribosylaminoimidazole succinocarboxamide synthetase (SAICARS, EC 6.3.2.6) (PAICS). The mutation reduced the catalytic activity of PAICS in heterozygous carrier and patient skin fibroblasts to approximately 50 and 10% of control levels, respectively. The catalytic activity of the corresponding recombinant enzyme protein carrying the mutation p.Lys53Arg expressed and purified from E. coli was reduced to approximately 25% of the wild-type enzyme. Similar to other two known DNPS defects-adenylosuccinate lyase deficiency and AICA-ribosiduria-the PAICS mutation prevented purinosome formation in the patient's skin fibroblasts, and this phenotype was corrected by transfection with the wild-type but not the mutated PAICS. Although aminoimidazole ribotide (AIR) and aminoimidazole riboside (AIr), the enzyme substrates that are predicted to accumulate in PAICS deficiency, were not detected in patient's fibroblasts, the cytotoxic effect of AIr on various cell lines was demonstrated. PAICS deficiency is a newly described disease that enhances our understanding of the DNPS pathway and should be considered in the diagnosis of families with recurrent spontaneous abortion or early neonatal death.
CZ OPENSCREEN Institute of Molecular Genetics Czech Academy of Sciences 140 00 Prague Czech Republic
Department of Biochemistry University of Cambridge CB2 1TN Cambridge UK
Department of Clinical Genetics Rigshospitalet 2100 Copenhagen Denmark
FarGen The Genetic Biobank of the Faroe Islands FO 100 Tórshavn Faroe Islands
Pediatric Unit Medical Department The Faroese Hospital System FO 100 Tórshavn Faroe Islands
Section on Nephrology Wake Forest School of Medicine 271 03 Winston Salem NC USA
Citace poskytuje Crossref.org
Expanding clinical spectrum of PAICS deficiency: Comprehensive analysis of two sibling cases
Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds
Combined Targeted and Untargeted Profiling of HeLa Cells Deficient in Purine De Novo Synthesis